Novo Nordisk Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Diabetes pandemic is fuelled by growing rates of obesity Obesity prevalence (BMI ≥30 kg/m²) US CDC data on obesity and diabetes prevalence among adults 1994 2000 Diabetes prevalence 2013 Slide 33 No Data <14.0% 14.0-17.9% 18.0-21.9% 22.0-25.9% >26.0% No Data <4.5% 4.5-5.9% 6.0-7.4% 7.5-8.9% >9.0% CDC: Centers for Disease Control and Prevention Source: CDC's Division of Diabetes Translation. National Diabetes Surveillance System available at http://www.cdc.gov/diabetes changing diabetes novo nordisk

View entire presentation